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Abstract
MicroRNAs (miRNAs) are small regulatory molecules that cause post-transcriptional gene silencing. Although some miRNAs
are known to have region-specific expression patterns in the adult brain, the functional consequences of the region-
specificity to the gene regulatory networks of the brain nuclei are not clear. Therefore, we studied miRNA expression
patterns by miRNA-Seq and microarrays in two brain regions, frontal cortex (FCx) and hippocampus (HP), which have
separate biological functions. We identified 354 miRNAs from FCx and 408 from HP using miRNA-Seq, and 245 from FCx and
238 from HP with microarrays. Several miRNA families and clusters were differentially expressed between FCx and HP,
including the miR-8 family, miR-182|miR-96|miR-183 cluster, and miR-212|miR-312 cluster overexpressed in FCx and miR-34
family overexpressed in HP. To visualize the clusters, we developed support for viewing genomic alignments of miRNA-Seq
reads in the Chipster genome browser. We carried out pathway analysis of the predicted target genes of differentially
expressed miRNA families and clusters to assess their putative biological functions. Interestingly, several miRNAs from the
same family/cluster were predicted to regulate specific biological pathways. We have developed a miRNA-Seq approach
with a bioinformatic analysis workflow that is suitable for studying miRNA expression patterns from specific brain nuclei.
FCx and HP were shown to have distinct miRNA expression patterns which were reflected in the predicted gene regulatory
pathways. This methodology can be applied for the identification of brain region-specific and phenotype-specific miRNA-
mRNA-regulatory networks from the adult and developing rodent brain.
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Introduction
MicroRNAs (miRNAs) are highly conserved small regulatory
molecules that cause post-transcriptional gene silencing by base
pairing with target messenger RNA (mRNA) [1]. MiRNAs are
processed from primary transcripts into ,70-nt stem-loop pre-
cursors in the nucleus by Drosha-DGCR (DiGeorge Critical
Region) complex, and then further cleaved by the Dicer enzyme in
the cytoplasm into ,23-nt functional sequences [2]. Mature
mammalian miRNAs bind to their specific target sequences on the
39-untranslated region (UTR) of mRNAs by imperfect base
pairing, leading to mRNA cleavage or translational repression
[3,4]. Because one miRNA may have hundreds of target mRNAs,
each miRNA has wide-reaching effects on gene expression, and
together with their target mRNAs they form non-linear gene
regulatory networks.
MiRNAs have diverse functions in the brain, including regula-
tion of neuronal development and differentiation, synapse formation
precursorand plasticity [5,6,7]. MiRNA expression levels seem to be
dynamic in the mammalian brain since they are altered by envi-
ronmental stimuli. For example, acute stress increases let-7a, miR-9
and miR-26a/b expression levels in the mouse frontal cortex (FCx),
but not in the hippocampus (HP) [8], and miR-212 signalling in the
rat striatum has a role in determining vulnerability to cocaine
addiction [9]. Therefore, it is not surprising that miRNAs have been
implicated in the etiology of several brain disorders, including
Alzheimer’s disease [10,11], Parkinson’s disease [12], schizophrenia
[13], aggressive behavior [14], depression [15], and anxiety disorders
[16,17].
MiRNAs play an important role during development, and some
miRNAs have specific temporal and spatial expression patterns
(e.g. [18,19,20]), suggesting that they control particular develop-
mental steps. In the adult brain, many miRNAs are widely
expressed, but there are also miRNAs that show enrichment in
specific brain regions [21,22]. There is evidence that region-specific
expression patterns of some miRNAs coincide with regional
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expression of their predicted target mRNAs [20], although it is
currently not known how widely this phenomenon applies. How-
ever, the region-specificity of mRNA expression is well-character-
ized in the mouse brain [23,24,25], and since miRNAs are
estimated to regulate the expression level of about 30% of the
mammalian mRNAs [26], it is likely that at least some regulatory
networks involving mRNAs and non-coding regulatory RNAs have
region-specific expression patterns.
Brain region-specific miRNA expression patterns of the adult
mouse have earlier been investigated with in situ hybridization,
qPCR, and microarrays [20,21]. The recent development of
massively parallel sequencing techniques has enabled profiling of
all expressed miRNAs in a given brain nucleus with a wide quan-
titative range, which is especially important in the brain where
many genes are expressed on a relatively low level [23]. Therefore,
we set out to investigate miRNA expression patterns in two brain
regions, FCx which is involved in the processing of cognitive
information and HP responsible for the context specificity and
learning and memory. MiRNA expression patterns from the adult
mouse brain were determined by miRNA-Seq using the Illumina
Genome Analyzer and by Affymetrix miRNA microarray. In-
terestingly, several miRNA families and clusters comprising of
multiple miRNAs were differentially expressed between FCx and
HP. To identify biological pathways regulated by differentially
expressed miRNAs, we predicted their target genes and carried
out pathway analysis. Different pathways were identified as being
enriched in FCx and HP emphasizing molecular diversity of these
brain regions.
Results
Identification of miRNAs from FCx and HP by miRNA-Seq
To determine miRNA expression patterns in FCx and HP, we
carried out miRNA-Seq using the Illumina Genome Analyzer II. We
developed an indexing protocol that is based on the 59 adaptor
modification. Three cDNA libraries prepared from the same total-
RNA and carrying different 6 bp indexes were sequenced individ-
ually, totaling three FCx and three HP samples (Figure S1). To test
how the indexes performed when used together, we sequenced one
library from both brain regions that contained equal amounts of each
three separate indexes pooled together. Obtained sequences were
trimmed and mapped against the miRBase, log2-transformed and
normalized to obtain a relative miRNA expression level for all
previously known miRNAs (see materials and methods for details).
It is known that indexes with different nucleotide sequences
might ligate to miRNAs with different efficacy [27]. To investigate
if there was a bias in miRNA expression patterns due to the three
different indexes, we calculated correlation coefficients for the pair-
wise comparisons of the three indexes (Figure S2). The correlation
coefficients varied from R2=0.803 to 0.907 indicating no major
ligation bias. Also, correlation between individually run and pooled
samples was high in both FCx (R2=0.976) and HP (R2= 0.978).
Because indexing did not significantly alter miRNA expression
patterns, differently indexed libraries were treated as technical repli-
cates in the subsequent analyses.
Sequencing of the libraries resulted in on average 6.22 million
(FCx) and 5.65 million (HP) short reads per library (Table 1),
which corresponded to 354 detected previously known miRNAs in
FCx and 408 in HP.
Identification of miRNAs from FCx and HP by Affymetrix
miRNA array
To compare miRNA expression patterns obtained by miRNA-
Seq with an independent method, we analyzed FCx and HP
miRNA expression also with Affymetrix GeneChipH miRNA
arrays. They contain four probe sets for each of the 609 mouse
miRNAs from the miRBase v11. Three biological replicates from
FCx and HP were analyzed on independent arrays. We detected
245 miRNAs from FCx and 238 from HP.
Comparison of the miRNA expression patterns obtained
by miRNA-Seq and microarrays
The number of miRNAs detected by both platforms was 212 in
FCx and 222 in HP (Figure 1A and B). We next analyzed the
similarities of the miRNA expression patterns obtained by the two
methods using two approaches. First, normalized count numbers
obtained from miRNA-Seq were plotted against normalized
microarray signal levels (Figure 1 C and D). The Spearman cor-
relation coefficient between the two methods was 0.50 in FCx and
0.49 in HP. Second, we ranked the miRNAs from both platforms
according to their normalized expression levels and compared the
similarities between the ordered lists giving more weight on the
Table 1. Bioinformatic workflow of miRNA-Seq data and the number of obtained reads.
Frontal Cortex Hippocampus
# of technical replicates 6 6
# of pre-filtered reads after base calling 6 223 794 5 652 753
# of sorted reads with indexes 5 554 153 5 246 449
Indexing efficiency (%) 89.2 92.8
Distribution of indexes (%):Index 3 (UUAGGC) 40.5 23.5
Index 7 (CAGAUC) 33.7 36.8
Index 11 (GGCUAC) 25.8 39.7
# of trimmed reads without mitochondrial and ribosomal sequences 1 778 620 4 387 680
# of reads aligning against mouse genome 1 043 842 3 546 816
# of reads aligning against miRBase 626 398 3 053 964
# of known miRNAs 415 446
# of reads aligning against miRBase with $2 reads 626 329 3 053 908
# of known miRNAs with $2 reads 354 408
doi:10.1371/journal.pone.0021495.t001
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miRNAs that were expressed on a high level (top ranks) or low
level (bottom ranks). According to the rank test, miRNA expres-
sion patterns from miRNA-Seq and microarrays were significantly
similar to each other both in FCx and HP (p-value ,0.001)
(Figure 1 E and F). These analyses suggested good correlation
between the two methods, as shown before [28].
Next, we examined the relative distributions of the most abun-
dant miRNAs by platform. Of the 15 most abundant miRNAs 10
were shared between both methods in FCx and seven in HP
(Figure 2). In miRNA-Seq data, the 15 most abundant miRNAs
constituted 86% of all counts in FCx and 87% in HP, while in the
microarray data, the 15 most abundant miRNAs constituted only
60% of the total signal in FCx and 63% in HP. As an example, let-
7c was highly expressed in both platforms but the proportion of its
expression level was much higher in miRNA-Seq (21% in FCx and
27% in HP of all counts) compared to its proportional expression
detected by microarrays (6% in FCx and 8% in HP of all signal).
This finding most likely reflects differences between the sample
preparation, including a PCR amplification step in the miRNA-Seq
but not in the microarray protocol, and the fact that the microarrays
Figure 1. Number of miRNAs detected by miRNA-Seq and microarrays, and comparison of the two platforms. Number of miRNAs
detected by miRNA-Seq (a) in frontal cortex and (b) in hippocampus. (c and d) Comparison of normalized count numbers from miRNA-Seq with
normalized signal intensity from microarrays in frontal cortex and hippocampus samples for miRNAs detected with both platforms. R2 = Spearman
correlation coefficient for pairwise comparison. Similarity of ranked expression value lists for (e) frontal cortex and (f) hippocampus resulting from
miRNA-Seq and microarrays as analyzed by the OrderedList package in R/Bioconductor. Expected refers to the expected overlap and 95% confidence
interval is shown. Both lists are more similar than expected by chance in the direct order (from the largest to the smallest expression value; P,0.001).
doi:10.1371/journal.pone.0021495.g001
Figure 2. The most abundant miRNAs in frontal cortex and hippocampus. Distribution of normalized counts (miRNA-Seq) or signal intensity
(microarrays) for the 15 most abundant miRNAs. (a)> miRNA-Seq from frontal cortex, (b) miRNA-Seq from hippocampus, (c) microarray from frontal
cortex, and (d) microarray from hippocampus.
doi:10.1371/journal.pone.0021495.g002
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contain probes for several species putatively allowing cross
hybridization and dilution of the signal of the conserved miRNAs.
Several miRNA families and clusters are differentially
expressed between FCx and HP
MiRNAs that are differentially expressed between FCx and HP
are expected to contribute to functional differences between the
brain regions. Therefore, we identified miRNAs that are dif-
ferentially expressed (p,0.05) between FCx and HP by miRNA-
Seq, microarrays or both (Table S1). We detected 36 differentially
expressed miRNAs (20 upregulated in FCx and 16 in HP) by
miRNA-Seq and 55 (28 upregulated in FCx and 27 in HP) by
microarrays. The overlap of the differentially expressed miRNAs
detected in both platforms, however, was relatively low with nine
miRNAs in FCx and four in HP. P-values derived from the
microarray and miRNA-Seq analyses are not independent, but
correlated. For that reason, widely accepted multiple testing cor-
rection methods, such as Holm-Bonferroni [29] and Benjamini-
Hochberg [30], produce strongly conservative and unrealistic
results. Applying Benjamini-Hochberg correction reduced the
number of differentially expressed miRNAs with FDR ,0.05 to
four in the case of microarray and 13 in miRNA-Seq. Taking into
account the nature of the data, multiple testing correction was not
used as a selection criterion for this study.
Interestingly, we identified several miRNA families and clusters
being differentially expressed between FCx andHP (Table 2). These
included miR-8 family overexpressed in FCx and comprising of
miRNAs from two chromosomal clusters, miR-429, miR-200a,
miR-200a*, miR-200b, and miR-200b* from chromosome 4, and
miR-141 and miR-200c from chromosome 6. Also, a chromosome
6 cluster with miR-182, miR-96, and miR-183 and a chromosome
11 cluster with miR-212 and miR-312 were expressed on a higher
level in FCx. Mir-34 family transcribed from a chromosome 9
cluster and including miR-34c, miR-34c*, miR-34b-3p, and miR-
34b-5p was expressed on a higher level in HP. Three miRNAs in
FCx (miR-128, miR-129-5p, and miR-344) and one miRNA in HP
(miR-7a) map to two chromosomal loci (Table S1). These data
suggest contribution of specific miRNA clusters and families in the
region-specific miRNA expression patterns. This finding is sup-
ported by previous observations regarding miRNA clusters regu-
lating specific signaling pathways [22,31].
Visualization of miRNA-Seq reads in their genomic context
To inspect the miRNA clusters in their genomic context we
added support for genomic alignments of miRNA-Seq reads in the
open source software Chipster Viewer (http://chipster.csc.fi/beta/).
The interactive genome browser of Chipster Viewer allows the
visualization of next generation sequencing data such as ChIP-Seq,
RNA-Seq and exome-Seq in the genomic context using Ensembl
annotations. It also contains preprocessing functionality which
converts SAM files to BAM format and performs sorting and
indexing for BAM files. As an example, Figure 3 shows visualization
of miR-8 family (miR-429, miR-200a, miR-200a*, miR-200b and
miR200b*) located on chromosome 4.
Target prediction of differentially expressed miRNAs
To identify target mRNAs for the differentially expressed
miRNAs, we carried out target prediction for all miRNAs detected
by either microarray or miRNA-Seq with differential expression
between FCx and HP. Out of the 39 miRNAs expressed on a
Table 2. MiRNA families and clusters differentially expressed between frontal cortex and hippocampus.
miRNAs over-
expressed in
FCx Chr Cluster # Detected by
Expression
level in FCx
by MA
Expression
level in HP
by MA
MiRNA-Seq
FCx count
concentration
MiRNA-Seq
HP count
concentration Fold change p-value
mmu-miR-429 4 1 MA; MS 3.57 2.05 7.46E-04 2.32E-05 2.86; 32.16 5.3E-03; 1.1E-08
mmu-miR-200a 4 1 MA; MS 3.45 1.56 1.36E-03 2.58E-05 3.69; 52.59 1.3E-02; 2.6E-10
mmu-miR-200a* 4 1 MS 1.04E-05 3.18E-07 32.86 4.3E-05
mmu-miR-200b 4 1 MA; MS 2.53 1.22 8.42E-04 2.62E-05 2.48; 32.19 5.0-E03; 1.1E-08
mmu-miR-200b* 4 1 MS 3.46E-05 8.20E-07 42.85 1.1E-07
mmu-miR-141 6 2 MS 4.16E-05 3.63E-07 118.58 8.2E-09
mmu-miR-200c 6 2 MA; MS 4.19 0.95 1.41E-04 5.44E-07 9.43; 263.86 5.6E-03; 7.8E-13
mmu-miR-182 6 3 MA; MS 5.47 1.81 5.38E-05 5.09E-07 12.58; 103.93 3.5E-04; 1.3E-09
mmu-miR-96 6 3 MS 8.74E-06 8.78E-16 FCx only 1.8E-05
mmu-miR-183 6 3 MS 5.10E-05 1.47E-07 336.12 4.9E-11
mmu-miR-212 11 4 MA; MS 8.91 8.28 4.54E-04 1.40E-04 1.55; 3.24 1.3E-02; 2.6E-02
mmu-miR-132 11 4 MA; MS 11.71 10.71 1.34E-02 3.56E-03 2.00; 3.77 1.8E-03; 1.2E-02
miRNAs
overexpressed
in HP
Chr Cluster # Detected by Expression
level in FCx
by MA
Expression
level in HP
by MA
MiRNA-Seq
FCx count
concentration
MiRNA-Seq
HP count
concentration
Fold change p-value
mmu-miR-34c 9 5 MA; MS 4.12 7.20 4.05E-05 1.42E-04 8.44; 3.49 1.3E-03; 2.0E-02
mmu-miR-34c* 9 5 MA 3.30 6.00 6.50 4.1E-04
mmu-miR-34b-3p 9 5 MA; MS 2.76 4.87 2.30E-06 1.49E-05 4.31; 6.59 7.3E-03; 5.6E-03
mmu-miR-34b-5p 9 5 MS 1.55E-06 1.61E-05 9.77 3.1E-04
Differentially expressed (P,0.05) miRNAs between frontal cortex and hippocampus and belonging to miRNA families or clusters are shown. Microarray data is given as
average normalized (log transformed) signal intensity. MiRNA-Seq count concentration refers to normalized expression levels from edgeR. Please see Table S1 for a full
list of differentially expressed miRNAs. FCx = frontal cortex, Chr = chromosome, Start = start position of the sequence in genomic alignment, End = end position of
the sequence in genomic alignment, AS = antisense, S = sense, MS = miRNA-Seq, MA = microarray.
doi:10.1371/journal.pone.0021495.t002
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Figure 3. Visualization of miRNA-Seq reads aligning to the chromosome 4 cluster of miR-8 family. The Chipster tool was used to
visualize the miR-8 family members located on chromosome 4 (miR-429, miR-200a, miR-200a*, miR-200b and miR200b*). As an example one sample
from (a) frontal cortex and one sample from (b) hippocampus were chosen (both sequenced with Illumina index # 11). The upper half shows the
number of sequences detected in the genomic region on a broad scale. The lower half zooms in on the reads detected for miRNA-200a and miR-
200a*. The different colors represent different nucleotides, making single nucleotide alterations (e.g., isomirs, single nucleotide polymorphisms, or
sequencing errors) easier to detect. Finally, the line graph represents the sequence coverage for each brain region before normalization.
doi:10.1371/journal.pone.0021495.g003
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higher level in the FCx and 39 expressed on a higher level in the
HP, nine and 10, respectively, were star miRNAs (Table S1). Since
miRWalk tool used for the target predictions does not consider star
sequences, they were omitted from further analyses. Number of
target genes predicted for each differentially expressed miRNA
varied from 12 (miR-676) to 826 (miR-495), with an average of
190 for miRNAs overexpressed in FCx and 132 in HP (Figure 4).
The majority of the predicted target genes were specific for the
corresponding brain region, however, 24% of target genes of
miRNAs detected by microarrays, 11% of those detected by
miRNA-Seq, and 10% of those detected by both methods were
shared by both brain regions (data not shown).
Pathway analysis of target mRNAs reveals biological
networks specific for each brain region
Gene regulatory networks composed of miRNAs and their target
mRNAs are expected to be important for the biological function of
the specific brain regions. Therefore, using Ingenuity Pathway
Analysis software, we carried out pathway analysis for miRNAs that
were differentially expressed between FCx and HP and that
belonged to miRNA clusters or families. These included miR-8,
miR-132, and miR-34 families and the miR-182|miR-96|miR-183
cluster. The analysis was carried out simultaneously for all miRNAs
belonging to the family or cluster, and the significantly over-
represented pathways (P,0.05) for each of them are shown in Table
S2. Interestingly, specific biological pathways were predicted to be
regulated by several miRNAs from the same family/cluster. Only
the ERK/MAPK signaling pathway was predicted to be regulated
by miRNAs that are expressed in both FCx and HP. Figure 5 shows
two example pathways, ceramide signaling regulated by two
miRNA families overexpressed in FCx and dopamine signaling
regulated by miRNAs overexpressed in HP.
Discussion
Understanding the function of miRNAs in the adult brain
requires investigation of brain region-specific miRNA expression
patterns. MiRNA-Seq provides a new and attractive method to
Figure 4. Number of predicted target genes for each miRNA differentially expressed between frontal cortex and hippocampus. All
miRNAs with differential expression (P,0.05) between frontal cortex and hippocampus are shown. Left panel lists miRNAs overexpressed in frontal
cortex and right panel miRNAs overexpressed in hippocampus. White bars denote miRNAs detected with miRNA-Seq, gray bars miRNAs detected by
microarrays, and black bars miRNAs detected by both platforms.
doi:10.1371/journal.pone.0021495.g004
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identify all miRNAs expressed in a given sample [32,33,34]. For
that reason, we set up a miRNA-Seq protocol with associated
bioinformatic workflow to identify miRNA expression patterns in
two brain regions, FCx and HP. MiRNA-Seq produces millions of
short sequences per run, a coverage which is not needed for the
profiling of miRNAs. Therefore, application of indexing with short
tags can increase throughput and reduce costs. At the time of this
study, commercial sample prep kits with indexing were not available
for the Illumina Genome Analyzer, and therefore we modified the
Illumina small RNA sample prep method slightly and attached six-
base-pair indexes to the 59 adaptor sequence. This indexing strategy
performed well and produced highly comparable results between
identical samples sequenced three times with different indexes. We
also set up a bioinformatics workflow for straightforward analysis of
miRNA-Seq data. As part of this workflow and to visualize the
genomic position of aligned miRNA-Seq reads, we added support
for miRNA-Seq data in the open source software Chipster Viewer.
It provides a user-friendly and efficient way to visualize data from
different massively parallel sequencing applications such as ChIP-
Seq, RNA-Seq and exome-Seq.
We compared miRNA expression patterns obtained by miRNA-
Seq with those obtained by Affymetrix miRNA arrays. Correlation
on the miRNA expression level was moderate (R2= 0.50 in FCx
and 0.49 in HP), as published earlier [28,35]. Interestingly, there
were some differences in the relative abundance of some miRNAs
between the platforms. For example, miR-709 was the most abun-
dant miRNA in FCx and HP as detected by microarrays. However,
in miRNA-Seq it was not detected at all in FCx and with very low
abundance (0–1 counts per library) in HP. Conversely, miR-9 was
among the most expressed miRNAs in miRNA-Seq data but poorly
detected by microarrays. These differences might be partly
attributed to the multi-organism probe content on the Affymetrix
array, as miR-709 is represented by mouse-specific probe sets, while
miR-9 has similar probe sets for 23 different organisms, all of which
were called ‘‘present’’ in our dataset. Another difference between
the methods is that miRNA-Seq sample prep contains a PCR
amplification step which is not present in the microarray protocol.
Overall, a larger number of miRNAs were detected by miRNA-Seq
compared to microarrays. Due to the differences between the plat-
forms, in the downstream analyses we concentrated on the set of
miRNAs that were detected by both methods.
Thirteen miRNAs were differentially expressed between FCx
and HP and detected by both platforms. Nine were upregulated in
FCx and four in HP. Interestingly, most of these differentially
expressed miRNAs belonged to miRNA families, including miR-8
and miR-132 families overexpressed in FCx and miR-34 family
overexpressed in HP, or miRNA clusters transcribed from the same
locus (miR-182|miR-183|miR-96 cluster overexpressed in FCx).
It has been established that a large proportion of mammalian
miRNAs cluster on chromosomes [36,37], and that miRNAs from
the same cluster tend to be co-transcribed implying polycistronic
transcription [38]. Interestingly, it seems that a miRNA cluster may
regulate functionally related genes within a biological pathway. For
example, miR17|miR-92 cluster is overexpressed in Myc-induced
tumor and regulates two genes involved in angiogenesis, TSP1 and
CTGF [39]. The miR-182|miR-183|miR-96 cluster, also identified
in our study, has previously been shown to regulate insulin signaling
pathway, with miR-96 and miR-183 mainly regulating Irs1 and
miR-182 targeting Rasa1 and Grb2 [31]. Our data also support this
notion. For example, in the ceramide pathway (Figure 5), miR132
and miR-212 were predicted to regulate Ras, Pi3k, Pp2a, and Tnfr1,
miR-200a to regulateNsmaf, Pp2a, andMap2k4, and miR-200b, miR-
200c, and miR-429 to regulate Ras, Pp2a, Map3k1, and Jun. In the
dopamine pathway (Figure 5) miR-34b-5p was predicted to regulate
Calcyon, Ppp2r, and Ppp1, miR-34b-3p to regulate Prka, and miR-
34 c to regulate Calcyon, Ppp2r and Ppp1.
We identified the ceramide signaling pathway by investigating
the predicted biological target pathways of miR-8 and miR-132
families, both of which were expressed on a higher level in FCx
compared to HP. Therefore, it is assumed that this pathway is
repressed in FCx. Sphingolipids, including ceramide, play an
important role in signal transduction in the membranes of neurons,
either by modulating the localization and activation of membrane-
associated receptors, or by acting as precursors of bioactive lipid
mediators [40]. Ceramides are activated by inflammatory cytokines
or oxidative stress, and participate in various physiological processes
including cell proliferation, cell differentiation, and apoptosis [40].
Excessive production of ceramides, especially in HP, have been
implicated in the pathological death of neurons that occurs in
ischemic stroke [41], Parkinson’s disease [42], and Alzheimer’s
disease [40].
Another interesting pathway we identified is the dopamine
receptor 1/calcyon signaling pathway regulated by members of the
miR-34 family expressed on a higher level in HP compared to FCx.
Calcyon is a single transmembrane protein that regulates dopamine
receptor 1 signaling. Genetic variants within the Calcyon gene
(DRD1IP) associate with attention deficit hyperactivity disorder
(ADHD) [43], and therefore it is interesting that transgenic mice
overexpressing human calcyon cDNA show locomotor hyperactiv-
ity and reduced anxiety-like behavior [44]. In the postmortem
brains of schizophrenia patients, calcyon is up-regulated in the
cortex and thalamus [45,46]. Therefore, this pathway clearly plays
an important role in the etiology of neuropsychiatric phenotypes.
In conclusion, miRNA-Seq proved to be a well suited method for
the analysis of miRNA expression patterns of specific brain nuclei.
As part of this study, we make publically available both miRNA-Seq
and microarray datasets of adult mouse FCx and HP which are
expected to benefit a number of neuroscientists and bioinformati-
cians. Several miRNA families and clusters were shown to be
differentially expressed between FCx and HP. Biological pathways
these families or clusters are predicted to target are highly spe-
cialized. Furthermore, we provide further support for the notion
that members of the same miRNA family or cluster target several
mRNAs within a biological pathway. Our work provides a starting
point for a systematic analysis of brain region-specific miRNA
regulatory networks in the adult brain to better understand their
involvement in various cellular functions and disease phenotypes.
Materials and Methods
Animals and tissue collection
All animal care conformed to the European Communities Coun-
cil Directive 86/609/EEC. According to the Finnish legislation (act
on the use of animals for experimental purposes 62/2006) tissue
collection as a terminal procedure does not require ethics committee
approval, however, the University of Helsinki internal approval for
Figure 5. Predicted signaling pathways regulated by differentially expressed miRNA-families in frontal cortex and hippocampus.
Pathway analysis of predicted target genes of differentially expressed miRNA families and clusters was carried out to assess their putative biological
functions. Specific pathways that are predicted to be regulated by several miRNAs from the same family/cluster were identified (for a list of pathways
see Table S2). (a) As an example, ceramide signaling pathway composed of miRNAs from miR-8 family and their predicted target genes is shown. (b)
Dopamine signaling pathway including miR-34 family members and their predicted target genes.
doi:10.1371/journal.pone.0021495.g005
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animal use (KEK09–044) was obtained as required. Six adult male
C57BL/6J (Charles River) mice were obtained at the age of seven
weeks and singly-housed for one week before dissections. Food and
water was available ad libitum, and mice were kept on a 12-h light-
dark schedule (light period 6 am-6 pm). After one week accli-
matization mice were sacrificed by cervical dislocation at 9 am. FCx
was dissected from a coronal slice spanning Bregma 23.5– 21.5.
HP was dissected as described earlier [47]. Tissues were snap frozen
in liquid nitrogen and stored at 280uC until RNA isolation.
Total RNA extraction
Tissue was homogenized using lysing matrixD tubes and the
Fastprep instrument (Q.Biogene, Carlsbad, CA) according to the
manufacturer’s recommendation. The extraction of total RNA
was performed using the TriReagent (Molecular Research Center,
Cincinnati, OH) also according to the manufacturer’s instructions.
RNA pellets were eluted to sequencing grade water (Amresco,
Solon, OH), and the quality of total RNA analyzed by the
Bioanalyzer Nano 6000 chip (Agilent Technologies, Santa Clara,
CA). Only samples with an RNA Integrity Number (RIN) greater
than 9.0 were used for further experiments.
Small RNA library preparation
Small RNA library preparation was based on Illumina’s Small
RNA Sample Prep kit v1.0 (Illumina Inc, San Diego, CA), except
that we added an index sequence to the 59 adaptor as described
below. All adaptor and primer sequences are based on Illumina’s
oligonucleotide sequences ( 2006–2008 Illumina, Inc. All rights
reserved). Three Illumina indexes were selected, all of which start
with the same nucleotide and differ from each other by at least two
nucleotides. FCx and HP samples from three mice were pooled
(Figure S1). Six samples were processed: 1) FCx with Illumina
index # 3, 2) FCx with Illumina index # 7, 3) FCx with Illumina
index # 11, 4) HP with Illumina index # 3, 5) HP with Illumina
index # 7, and 6) HP with Illumina index # 11. For each sample,
10 mg of total RNA was size fractionated using a 15% Novex gel
(Invitrogen, Carlsbad, CA) and fractions corresponding to 15–35
nucleotides were excised. RNA was eluted by shaking the gel slices
in 300 ml of 0.3 M NaCl for 4 h at RT. The resulting gel slurries
were passed through a Spin-X filter column (Corning, NY). 750 ml
of 100% ethanol and 1 ml of mussel glycogen (20 mg/ml; Roche)
were added and the samples were precipitated for 30 minutes at
280uC. Samples were centrifuged 14000 rpm for 25 minutes at
4uC. After washing with 85% ethanol, pellets were allowed to air
dry at 25uC, and the samples were resuspended in 5.7 ml of
sequencing grade water (Amresco, Solon, OH).
The 59 RNA adaptors containing three different six-nucleotide
tags were ordered from Metabion GmbH (Martinsried, Germany).
Indexing was based on the multiplexing protocol used for DNA
sequencing by Illumina (Oligonucleotide sequences  2006–2008
Illumina, Inc. All rights reserved). The sequences of the 59 RNA
adaptors were: Index 3 (59-GUUCAGAGUUCUACAGUCCG-
ACGAUC UUAGGC-39); Index 7 (59-GUUCAGAGUUCUACA-
GUCCGACGAUC CAGAUC-39); and Index 11 (59-GUUCAGA-
GUUCUACAGUCCGACGAUC GGCUAC-39). These 59RNA
adaptors (1.3 ml; 5 mM) were ligated to the small RNA samples
with T4 RNA ligase 1 (1.0 ml; New England Biolabs; NEB;
Ipswich, MA) in the presence of RNase inhibitor (1.0 ml; NEB) for
6 h at 20uC. The ligation reaction was stopped by the addition of
26RNA loading dye (Fermentas GmbHSt. Leon-Rot, Germany).
The ligated RNA was size fractionated using a 15% Novex gel,
and a 40–75 nucleotide fraction was excised. RNA was eluted from
the excised gel slices by shaking them in 300 ml of 0.3 M NaCl for
4 h at RT. The resulting gel slurries were passed through a Spin-X
filter column. 750 ml of 100% ethanol and 1 ml of mussel glycogen
(20 mg/ml) were added and the samples were precipitated for 30
minutes at 280uC. The samples were immediately centrifuged at
14000 rpm for 25 minutes at 4uC. After washing with 85% ethanol,
the pellets were allowed to air dry at 25uC, and the samples re-
suspended in 6.4 ml of sequencing grade water.
The 39 RNA adaptor (0.6 ml; 10 mM; 59-pUCGUAUGCCGU-
CUUCUGCUUGidT-39; p, phosphate; idT, inverted deoxythy-
midine; Metabion) was subsequently ligated to the precipitated
RNA using the same reaction conditions as in the 59 ligation step.
The ligated RNA was size fractionated using a 10% Novex gel, and
the 60–100 nucleotide fraction was excised. RNA was eluted from
the excised gel slices by shaking them in 300 ml of 0.3 M NaCl for
4 h at RT. The resulting gel slurries were passed through a Spin-X
filter column. 750 ml of 100% ethanol and 1 ml of mussel glycogen
(20 mg/ml) were added and the samples were precipitated for 30
minutes at 280uC. The samples were immediately centrifuged at
14000 rpm for 25 minutes at 4uC. After washing with 85% ethanol,
the pellets were allowed to air dry at 25uC, and the samples resu-
spended in 4.5 ml of sequencing grade water. The products con-
taining miRNAs flanked by 59 and 39 adaptors were converted to
cDNA using Superscript II reverse transcriptase (Invitrogen) and
Illumina’s small RNA RT-Primer (59-CAAGCAGAAGACGG-
CATACGA-39) following the manufacturer’s instructions. The
resulting cDNA was PCR-amplified with PhusionHHot Start DNA
Polymerase (Finnzymes, Espoo, Finland) for 15 cycles using Illu-
mina’s small RNA primer set (59-CAAGCAGAAGACGGCA-
TACGA-39; 59-AATGATACGGCGACCACCGA-39).
The amplification products were purified using a 6% Novex
TBE gel (Invitrogen) and the 80–140 nucleotide fractions were
excised and eluted in 100 ml of elution buffer (NEB) for 2 h at RT.
The resulting gel slurry was passed through a Spin-X filter and
precipitated by the addition of 325 ml of 100% ethanol, 10 ml of
3 M sodium acetate, and 1 ml glycogen (20 mg/ml). The samples
were centrifuged at 14000 rpm for 20 minutes. After washing with
70% ethanol, the pellet was dried in a SpeedVac (Thermo Fisher
Scientific) and dissolved in 10 ml of sequencing grade water. cDNA
was PCR-amplified with PhusionH Hot Start DNA Polymerase
(Finnzymes, Espoo, Finland) for 15 cycles using Illumina’s small
RNA primer set (59-CAAGCAGAAGACGGCATACGA-39 and
59- AATGATACGGCGACCACCGACAGGTTCAGAGTTCT-
ACAGTCCGA-39). Purified PCR products were quantified by
Bioanalyzer DNA 1000 chip (Agilent).
Sequencing of small RNA libraries
Small RNA libraries were diluted in sequencing grade water to
obtain 10 nM concentration. A total of eight flow cell lanes were
used to sequence the following samples: 1) FCx with Illumina
index # 3, 2) FCx with Illumina index # 7, 3) FCx with Illumina
index # 11, 4) a pool of 1–3, including 3.3 nM concentration of
each sample, 5) HP with Illumina index # 3, 6) HP with Illumina
index # 7, 7) HP with Illumina index # 11, and 8) a pool of 5–7,
including 3.3 nM concentration of each sample (Figure S1).
Sequencing was performed with the Illumina Cluster Station and
Genome Analyzer II according to manufacturer’s protocols using
36 alternating cycles of enzymatic synthesis and optical interro-
gation. Sequence reads were extracted from the image files using
the GAPipeline software v 1.4.0 (Illumina San Diego, CA, USA).
Small RNA sequence data analysis
Only reads with an index sequence were retained, and in case of
the pooled samples sequences were divided into separate files
according to the index. Reads were trimmed by removing the
index sequence and the 39 adaptor sequence. Subsequently,
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sequences including adaptor dimers, mitochondrial or ribosomal
sequences were discarded. Additionally, reads that contained homo-
polymers (i.e., one nucleotide appearing more than 80% of the
entire short read) or were shorter than 14 nt were removed. The
resulting set of trimmed reads were then mapped against the mouse
genome (Mus_musculus.NCBIM37.55) and to known mature
miRNAs (miRBase version 11; April 15, 2008; http://www.
mirbase.org/) [48,49,50,51]. Version 11 of miRBase was selected
because it was used in the probe-design of the Affymetrix micro-
array. The alignments were performed using Bowtie [52] allowing
for two mismatches, because this generated the highest correlation
between the miRNA-Seq and Affymetrix microarray data (data not
shown). MiRNAs detected with only one count were eliminated
from further analyses. Expression analysis of miRNA-Seq data was
performed with the R/Bioconductor package EdgeR [53], which is
designed for use with digital gene expression data. EdgeR was chosen
because it moderates common dispersion in miRNA-Seq data in a
complementary fashion to the limma package moderation of probe-
wise variation in microarray data. Count numbers of each miRNA
were imported to EdgeR, log2 transformed, and normalized based
on negative binomial distribution to obtain a normalized miRNA
expression levels (Table S3). This dataset is available through GEO
with an accession number GSE27979. Differential expression of
miRNAs between FCx and HP was assessed in EdgeR by calculating
an exact test p-value analogous to the Fisher’s exact test. The
correlation analysis of differently indexed libraries was performed
with nonparametric Spearman’s test, because miRNA-Seq data was
not normally distributed.
Affymetrix miRNA microarray
Onemg of three FCx and three HP samples was labeled with
FlashTagTM Biotin RNA Labeling Kit (Genisphere, Hatfield, PA,
USA) for Affymetrix GeneChipH miRNA arrays (Affymetrix,
Santa Clara, CA, USA) according to the manufacturer’s recom-
mendations. A simple colorimetric Enzyme Linked Oligosorbent
Assay (ELOSA) was used to confirm successful biotin labeling.
After labeling, the samples were hybridized on Affymetrix Gene-
ChipH miRNA arrays, washed, stained, and scanned according to
manufacturer’s instructions (Affymetrix, Santa Clara, CA, USA).
The data files (.CEL) were imported to R/Bioconductor [54]. The
affy package [55] was used for preprocessing the raw data with all
probes for mouse miRNAs. The RMA method [56] was used to
perform background adjustment, quantile normalization and
summarization of the log-expression values for each gene on each
array (Table S4). This dataset is available through GEO with an
accession number GSE27891. We performed a differential ex-
pression analysis using methods implemented in the limma pack-
age, which uses an empirical Bayes method to moderate the
standard errors of the estimated log2-fold changes (logFC) [57].
We determined the present/ absent calls with Affymetrix miRNA
QC tool, and selected those miRNAs in each brain region with$2
replicates detected as present for further analyses.
Comparison of the expression level of miRNAs across
platforms
Comparison of the miRNA expression levels measured by
miRNA-Seq and microarray was performed with the OrderedList
package [58] implemented in R/Bioconductor. For this test, we
ranked miRNAs from miRNA-Seq and microarray data separate-
ly based on their expression levels in FCx and in HP (normalized
count numbers in miRNA-Seq and normalized signal intensity in
microarray data). OrderedList calculates similarity scores between
two ordered lists and determines empirical p-values for the
similarity. When computing the similarity score, more weight was
given to miRNAs at the ends of the lists. The significance of simi-
larity scores was estimated from random scores with 1000 per-
mutations.
Visualization of miRNA-Seq reads
Support for viewing miRNA-Seq data was added to the open
source software Chipster Viewer. The genomic alignments of the
reads were visualized using the Ensembl release 59 annotations
and NCBI m37 mouse genome as a reference.
Target prediction
MiRNAs from both platforms with significantly different ex-
pression (p,0.05) between FCx and HP were selected for target
prediction. Currently, there exists no single bioinformatic tool with
statistically significant accuracy (i.e. low false positive rates) in
predicting miRNA binding sites. However, integration of various
computational methods is a common approach to improve pre-
diction accuracy and to create an optimal framework for deci-
phering biological functions of miRNAs [59]. We used the
miRWalk database (http://www.ma.uni-heidelberg.de/apps/zmf/
mirwalk/), which takes into account these issues. MiRWalk’s major
function is to report predicted miRNA-mRNA interactions on the
39 UTRs of known genes calculated by several established target
prediction programs. Of the programs available within the
miRWalk database, TargetScan [60] and miRanda [61] were selected
for being well-established algorithms of seed and sequence com-
plementarity with conservation of binding sites across multiple
species. Three additional programs were chosen to represent
newer but increasingly popular methods for target prediction.
RNA22 [62] first identifies putative miRNA binding sites in the
sequence of interest following identification of targeting miRNAs.
RNAhybrid [63] uses a thermodynamic approach to find energet-
ically favorable hybridization sites between a set of miRNAs and
candidate targets. MiRDB [64] is a database containing genes
predicted to be downregulated by miRNAs with MiRTarget2, a
prediction program based on support vector machines. The five
selected target prediction algorithms represent a unique combi-
nation of specificity and sensitivity to potential miRNA-mRNA
target gene interactions. Statistically significant miRNA-mRNA
relationships were extracted from the MiRWalk results using two
criteria: an independently calculated Poisson p-value ,0.05 for
multiple binding sites in a predicted gene, and identification by at
least two of the five selected target prediction algorithms.
Pathway analysis of target genes
Lists of predicted target genes for the differentially expressed
miRNA families or clusters were used for input to Ingenuity Pathway
Analysis (IngenuityH Systems, http://www.ingenuity.com) with
default parameters but a restriction on the results to only the
mouse species. This identified known and most relevant biological
functions, pathways and annotations in each enriched set of mouse
target genes. Further analysis with the tools (as described in the
Results) identified biological characteristics such as co-expressional
relationships between miRNAs, and assisted in forming statistically
supported hypotheses of the true functional roles of miRNAs
targeting key genes in a biological pathway.
Supporting Information
Figure S1 Sample preparation and sequencing work-
flow of miRNA-Seq. Frontal cortex and hippocampi from three
adult C57BL/6J mice were dissected and pooled after which total
RNA was extracted. Three miRNA libraries were generated from
both frontal cortex and hippocampus. Each library was tagged
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with a different 6-nucleotide index sequence. Eight flow cell lanes
were used for sequencing, containing the three frontal cortex and
three hippocampus libraries and from both brain regions a pooled
sample in which the three indexed libraries were run in 1:3.
(PDF)
Figure S2 The effect of indexing on the sample similar-
ity. Count numbers of each miRNA were imported to EdgeR, log2
transformed, and normalized based on negative binomial distri-
bution to obtain a relative miRNA expression level. Correlation
coefficient was calculated with nonparametric Spearman’s test.
Index 3, 7, and 11 refer to libraries in which all sequences have
this particular index. Single lanes contain averaged information of
indexes 3, 7, and 11 (3 technical replicates). Pooled lanes refer to
the library in which the same sample with three different indexes
was run in a single flow cell lane. Merged lanes contain infor-
mation from the three individually ran libraries (single lanes), and
the pooled library (6 technical replicates). Green boxes indicate
FCx libraries and red boxes HP libraries.
(PDF)
Table S1 MiRNAs differentially expressed between
frontal cortex and hippocampus. Differentially expressed
(P,0.05) miRNAs between frontal cortex and hippocampus. FCx
= frontal cortex, Chr = chromosome, Start = start position of
the sequence in genomic alignment, End = end position of the
sequence in genomic alignment, AS = antisense, S = sense, MS
= miRNA-Seq, MA = microarray. MiRNA-Seq count concen-
tration refers to normalized expression levels from edgeR.
(XLSX)
Table S2 Pathways of predicted target genes for miRNA
clusters and families detected as differentially expressed
between FCx and HP. Target genes were predicted using
miRWALK for miRNAs belonging to the differentially expressed
families/clusters. IPA software was used to identify biological
pathways over-represented within the target genes of each family/
cluster. Overlap is the number of targets in the dataset over the
total number of molecules in the pathway.
(PDF)
Table S3 MiRNA expression levels detected by miRNA-
Seq. ConcFCx and ConcHP are the normalized expression levels
from edgeR for Frontal Cortex (FCx) and Hippocampus (HP).
LogFC is the log-transformed fold change of HP over FCx. P-
value is calculated by edgeR and is analogous to a p-value from
the Fisher’s Exact Test. BenjHoch-PVal is the p-value after
multiple testing correction using the Benjamini-Hochberg method.
Lane values are expression levels normalized to the geometric
mean of each library by edgeR.
(XLSX)
Table S4 Expression levels of miRNAs detected by
microarrays. LogFC refers to the logarithmic fold change calcu-
lated as hippocampus over frontal cortex. P-value is given for
differential expression. Expression values for each sample represent
normalized log-transformed signal intensities.
(XLSX)
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